Goldman SachsGSWAITJan 13, 2025Stock price when the opinion was issued
As of Jul 20, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
Banks in both the US and Canada look pretty good, though the US market is stronger. GS's chart has been in a strong uptrend since late 2023, though recent weakness sees it falling back to that trendline. Hope that it bounces off that and buy. You don't want to see the stock fall further down. See if it holds before buying.